SEC Form 4 · accession 0001104659-19-003714
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey Gilmore
Officer — General Counsel
Period of report
Jan 24, 2019
Accepted (ET)
Jan 28, 2019 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 24, 2019 | M | 16,480 | — | A | 28,212 | D | |
| Common StockF1 | Jan 25, 2019 | M | 17,500 | — | A | 45,712 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 24, 2019 | M | 16,480 | D | — | — | Common Stock | 16,480 | 17,500 | D |
| Restricted Stock UnitsF1,F3 | — | Jan 25, 2019 | M | 17,500 | D | — | — | Common Stock | 17,500 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2On January 24, 2018 the reporting person was granted 16,480 restricted stock units that fully vested and were delivered on January 24, 2019.
- F3On January 25, 2017, the reporting person was granted 35,000 restricted stock units that vest as follows: 17,500 units vested and were delivered on January 25, 2018, and 17,500 units vested and were delivered on January 25, 2019.